Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients

Summary

This study was performed to determine the incidence, risk factors, and prognostic implications of venous thromboembolism (VTE) in Asian patients with colorectal cancer (CRC). Differences in clinical characteristics and prognostic impact between extremity venous thrombosis (or deep-vein thrombosis; DVT)/pulmonary embolism (PE) and intra-abdominal venous thrombosis (IVT) were also evaluated. For this study, consecutive CRC patients (N = 2,006) were enrolled and analyses were conducted retrospectively. VTEs were classified into two categories (DVT/PE and IVT). Significant predictors of developing VTEs were advanced stage and an increased number of co-morbidities. The two-year cumulative incidence of DVT/PE was 0.3%, 0.9% and 1.4% in stages 0~1, 2 and 3, respectively; this incidence range of DVT/PE in Asian patients with loco-regional CRC was lower than in Western patients. However, the two-year incidence (6.4%) of DVT/PE in Asian patients with distant metastases was not lower than in Western patients. Although 65.2% of patients with DVT/PE were symptomatic, only 15.7% of patients with IVT were symptomatic. During chemotherapy, DVT/PE developed more frequently than IVT. Only DVT/PE had a negative effect on survival; IVT had no prognostic significance. In conclusion, despite the low incidence of DVT/PE in Asian patients with loco-regional CRC, the protective effect of Asian ethnicity on VTE development disappears as tumour stage increases in patients with distant metastases. Considering different clinical characteristics and prognostic influences between DVT/PE and IVT, the treatment approach should be also different.

Keywords

Venous thromboembolism - colorectal cancer - incidence - prognosis - ethnicity

^* These two authors equally contributed to this study.

^** The results in this article were presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis (ISTH), Kyoto, Japan, 23–28 July 2011.

• References

• 1 Chew HK, Wun T, Harvey D. et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-464.
• 2 Alcalay A, Wun T, Khatri V. et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24: 1112-1118.
• 3 Mandala M, Barni S, Floriani I. et al. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings. Eur J Cancer 2009; 45: 65-73.
• 4 Simonneau G, Laporte S, Mismetti P. et al. A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. J Thromb Haemost 2006; 4: 1693-1700.
• 5 Stender MT, Nielsen TS, Frokjaer JB. et al. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer. Br J Surg 2007; 94: 1100-1103.
• 6 Chew HK, Wun T, Harvey DJ. et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 2007; 25: 70-76.
• 7 Lee KW, Bang SM, Kim S. et al. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer. J Thromb Haemost 2010; 8: 540-547.
• 8 Oh SY, Kim JH, Lee KW. et al. Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res 2008; 122: 485-490.
• 9 Lyman GH, Khorana AA, Falanga A. et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25: 5490-5505.
• 10 Won YJ, Sung J, Jung KW. et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat 2009; 41: 122-131.
• 11 Park JS, Kang SB, Kim SW. et al. Economics and the laparoscopic surgery learning curve: comparison with open surgery for rectosigmoid cancer. World J Surg 2007; 31: 1827-1834.
• 12 Kang SB, Park JS, Kim DW. et al. Intraoperative technical difficulty during laparoscopy-assisted surgery as a prognostic factor for colorectal cancer. Dis Colon Rectum 2010; 53: 1400-1408.
• 13 Elixhauser A, Steiner C, Harris DR. et al. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
• 14 Kakkar AK. Prevention of venous thromboembolism in the cancer surgical patient. J Clin Oncol 2009; 27: 4881-4884.
• 15 Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011; 9: 85-91.
• 16 Rodriguez AO, Wun T, Chew H. et al. Venous thromboembolism in ovarian cancer. Gynecol Oncol 2007; 105: 784-790.
• 17 Chew HK, Davies AM, Wun T. et al. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008; 6: 601-608.
• 18 Sandhu R, Pan CX, Wun T. et al. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Cancer 2010; 116: 2596-2603.
• 19 Semrad TJ, O'Donnell R, Wun T. et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 2007; 106: 601-608.
• 20 Ku GH, White RH, Chew HK. et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009; 113: 3911-3917.